Abstract
T cells from systemic lupus erythematosus (SLE) patients exhibit defective function of CD4+ T cells that can be responsible for improper activation of B cells and antibody biosynthesis against host antigens. We compared the level of ZAP-70, LAT, and SLP-76, transcripts and proteins in CD4+ T cells from SLE patients (n = 22) and healthy individuals (n = 15). We also determined DNA methyltransferase 1 (DNMT1) protein content in CD4+ T cells of SLE patients. The CD4+ T cells were isolated by positive biomagnetic separation technique. The quantitative analysis of messenger RNA (mRNA) was performed by reverse transcription and real-time quantitative polymerase chain reaction (RQ-PCR) SYBR Green I system. The protein level in the CD4+ T cells was determined by Western blotting analysis. We found that the LAT protein level was significantly higher in SLE CD4+ T cells than in controls (P = 0.006). Western blot analysis revealed that ZAP-70 protein content in SLE CD4+ T cells may be reciprocally correlated with disease activity expressed in SLEDAI scale (R = −0.623, P = 0.002) or number of affected organ systems (R = −0.549, P = 0.008). We also observed reciprocal correlation between DNMT1 protein content in CD4+ T cells and disease activity scored with SLEDAI scale (R = −0.779, P = 0.001) or number of affected organ systems (R = −0.617, P = 0.019), respectively. Our findings might indicate that LAT, ZAP-70, and DNMT1 protein levels in CD4+ T cells can be associated with SLE disease.
Similar content being viewed by others
References
Mageed RA, Prud’homme GJ (2003) Immunopathology and the gene therapy of lupus. Gene Ther 10:861–874
Herrmann M, Winkler T, Gaipl U, Lorenz H, Geiler T, Kalden JR (2000) Etiopathogenesis of systemic lupus erythematosus. Int Arch Allergy Immunol 123:28–35
Krieg AM (1995) CpG DNA: a pathogenic factor in systemic lupus erythematosus? J Clin Immunol 15:284–292
Kono DH, Theofilopoulos AN (1996) Genetic contributions to SLE. J Autoimmun 9:437–452
Riemekasten G, Hahn BH (2005) Key autoantigens in SLE. Rheumatology 44:975–982
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum 25:1271–1277
Hochberg MC (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum 40:1725
Krishnan S, Farber DL, Tsokos GC (2003) T cell rewiring in differentiation and disease. J Immunol 171:3325–3331
Tsokos GC, Liossis SN (1999) Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 20:119–124
Nel AE (2002) T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. Clin Immunol 109:758–770
Bernard A, Coitot S, Bremont A, Bernard G (2005) T and B cell cooperation: a dance of life and death. Transplantation 79:8–11
Krishnan S, Warke VG, Nambiar MP, Tsokos GC, Farber DL (2003) The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J Immunol 170:4189–4195
Clements JL, Boerth NJ, Lee JR, Koretzky GA (1999) Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu Rev Immunol 17:89–108
Shaw AS, Dustin ML (1997) Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6:361–369
Butkiewicz L, Duriagin S, Laddach R, Chwalinska-Sadowska H, Jagodzinski PP (2005) Prevalence of Fc-gammaR chain expression in CD4+ T cells of patients with systemic lupus erythematosus. Scand J Rheumatol 34:216–219
Richardson B, Powers D, Hooper F, Yung RL, O’Rourke K (1994) Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 37:1363–1372
Richardson B, Yung R (1999) Role of DNA methylation in the regulation of cell function. J Lab Clin Med 134:333–340
Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M (1990) Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33:1665–1673
Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, Richardson B (2004) Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 46:1282–1291
Januchowski R, Prokop J, Jagodzinski PP (2004) Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet 45:237–248
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162:156–159
Enyedy EJ, Nambiar MP, Liossis SN, Dennis G, Kammer GM, Tsokos GC (2001) Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum 44:1114–1121
Hussain SF, Anderson CF, Farber DL (2002) Differential SLP-76 expression and TCR-mediated signaling in effector and memory CD4 T cells. J Immunol 168:1557–1565
Krishnan S, Nambiar MP, Warke VG, Fisher CU, Mitchell J, Delaney N, Tsokos GC (2004) Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J Immunol 172:7821–7831
Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA (2004) The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Br J Dermatol 150:693–700
Krishnan S, Warke VG, Nambiar MP, Wong HK, Tsokos GC, Farber DL (2001) Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression. Blood 97:3851–3859
Penna D, Muller S, Martinon F, Demotz S, Iwashima M, Valitutti S (1999) Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway. J Immunol 163:50–56
Haczku AF, Kay B, Corrigan CJ (1996) Inhibition of re-expression of surface cd4, but not cd8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine a: correlation with inhibition of proliferation. Int J Immunopharmacol 18:45–52
Bryl E, Gazda M, Foerster J, Witkowski J (2001) Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4. Blood 98:1100–1107
Yang J, Deng C, Hemati N, Hanash SM, Richardson BC (1997) Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol 159:1303–1309
Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, Hanash SM, Richardson BC (2001) Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 44:397–407
Richardson BC, Strahler JR, Pivirotto TS, Quddus J, Bayliss GE, Gross LA, O’Rourke KS, Powers D, Hanash SM, Johnson MA (1992) Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 35:647–662
Acknowledgements
Supported by grant nos. 2P05B01927 and 2P05B18929 from Polish Ministry of Scientific Research and Information Technology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Januchowski, R., Wudarski, M., Chwalińska-Sadowska, H. et al. Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus. Clin Rheumatol 27, 21–27 (2008). https://doi.org/10.1007/s10067-007-0644-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0644-8